Global Scandium-43 Market Growth 2026-2032
The global Scandium-43 market size is predicted to grow from US$ 15.12 million in 2025 to US$ 46.75 million in 2032; it is expected to grow at a CAGR of 18.6% from 2026 to 2032.
In 2025, global Scandium-43 production was approximately 112 grams, with an average global market price of around $138,000 per gram. That year, total global production capacity for Scandium-43 reached approximately 350 grams. The industry's average gross profit margin stood at approximately 64%. Scandium-43 (?³Sc) is an artificial radioactive isotope of the transition metal scandium (Sc), with an atomic number of 21 and a mass number of 43. While scandium exists in nature primarily as the stable isotope scandium-45 (??Sc), ?³Sc does not occur naturally in significant quantities and must be produced via artificial nuclear reactions. With a half-life of approximately 3.89 hours, ?³Sc decays primarily via ?? emission into stable calcium-43 (?³Ca), releasing positrons in the process; this makes it a promising candidate for Positron Emission Tomography (PET) applications. Due to its short half-life, high positron emission fraction, and chemical properties suitable for ligand labeling, research on ?³Sc focuses on molecular imaging in nuclear medicine, radiopharmaceutical development, and the creation of novel PET imaging agents. Compared to established PET radionuclides like fluorine-18 (??F) and gallium-68 (??Ga), ?³Sc remains in the stages of research, development, and exploratory application; however, its excellent compatibility with scandium-based coordination chemistry positions it as a promising new radionuclide for the future of precision diagnostics in nuclear medicine.
The upstream segment of the ?³Sc industry chain encompasses the supply of stable scandium resources, the production of high-purity scandium target materials, isotope production facilities, and nuclear equipment such as cyclotrons. Since scandium exists in nature predominantly as the stable isotope ??Sc, ?³Sc must be generated through artificial nuclear reactions. Common production methods involve using enriched calcium, titanium, or scandium targets and subjecting them to nuclear reactions—such as proton bombardment—within a cyclotron. This upstream phase entails the preparation of high-purity target materials, the control of nuclear reaction parameters, and the construction of radionuclide production facilities, all of which demand advanced equipment and technical expertise. Given the inherent scarcity of scandium resources—which are primarily derived as by-products of rare earth and uranium mining or recovered during other mineral processing operations—the supply capacity for high-purity scandium materials is a critical factor influencing ?³Sc production. The global scale of scandium resource development and production remains limited, with supply concentrated among a few nations and institutions possessing capabilities in resource extraction and nuclear technology. The midstream of the Scandium-43 (?³Sc) value chain encompasses nuclear reactor-based production, radiochemical separation, purification, and the development of radiopharmaceutical labeling technologies. As accelerator-based production inevitably generates other scandium isotopes or impurity nuclides, radiochemical methods—such as ion exchange, solvent extraction, and chromatography—are required to obtain ?³Sc products with high radiochemical purity. Depending on application requirements, ?³Sc is typically supplied in chemical forms like scandium chloride solution and subsequently conjugated with targeting ligands, antibody fragments, or small-molecule drugs to develop radiotracers for PET imaging. The core technical challenges in the midstream sector involve maximizing nuclide yield, minimizing impurity levels, and achieving rapid labeling reactions to accommodate the constraints imposed by the relatively short half-life of ?³Sc. Current research on ?³Sc focuses primarily on developing novel PET imaging agents, evaluating radiopharmaceuticals, and establishing experimental platforms for nuclear medicine. Downstream applications of ?³Sc include nuclear medicine imaging, radiotracer research, and the development of precision diagnostic technologies. PET molecular imaging represents the most promising application area for ?³Sc; its positron-emitting properties enable the production of PET tracers for visualizing in vivo biodistribution, disease target expression, and drug metabolism. Additionally, ?³Sc is utilized in radiopharmaceutical R&D, tumor-targeted imaging, and research into novel theranostic (combined diagnostic and therapeutic) agents. Compared to traditional PET nuclides, ?³Sc offers advantages such as excellent compatibility with scandium coordination chemistry and nuclear properties well-suited for medical imaging; however, its adoption is currently constrained by factors including production costs, supply stability, and a lack of sufficient clinical validation. Looking ahead, advancements in compact cyclotron technology, rising demand for nuclear medicine diagnostics, and progress in novel radiopharmaceutical development position ?³Sc to become a significant complementary nuclide in the field of PET molecular imaging.
The primary driver for the development of Scandium-43 (?³Sc) is the advancement of precision medicine and nuclear medicine imaging technologies. As a positron-emitting radioisotope, ?³Sc undergoes ?? decay to produce positrons, enabling Positron Emission Tomography (PET) imaging that precisely visualizes human tissue metabolism, disease target expression, and drug distribution. With the continuous evolution of early tumor diagnosis, personalized therapy, and molecular imaging, market demand for novel PET radionuclides is steadily rising. Compared to traditional PET radionuclides, ?³Sc offers superior coordination chemistry compatibility, allowing it to bind with various targeting molecules to create new imaging agents—a feature that has attracted significant interest from nuclear medicine research institutions and radiopharmaceutical companies. Looking ahead, the adoption of precision diagnosis and treatment models, combined with the entry of more scandium-based PET tracers into the R&D pipeline, is expected to drive the expansion of ?³Sc applications.
In recent years, the radiopharmaceutical industry has been shifting from purely diagnostic applications toward an integrated "diagnosis and therapy" (theranostics) model, creating new opportunities for novel radionuclides like ?³Sc. Beyond its use in PET imaging research, ?³Sc complements scandium-based therapeutic radionuclide systems, facilitating drug screening, the evaluation of targeting molecules, and the design of treatment regimens. In the field of precision oncology, researchers are exploring the use of unified ligand systems to transition seamlessly between diagnostic imaging and radiotherapy; this trend is fueling demand for novel radionuclides that exhibit excellent chemical labeling properties. Furthermore, as radiopharmaceutical companies expand their pipelines for innovative drugs, the need for a reliable supply of high-purity radionuclides for research purposes is growing, further propelling the development of the ?³Sc industry.
A critical constraint on the development of the ?³Sc industry is the ability to ensure a stable supply. Due to its short half-life (approximately 3.89 hours), ?³Sc cannot be stored or transported over long distances for extended periods; consequently, production typically relies on cyclotron facilities located in close proximity to end-use sites. Recent advancements in compact medical cyclotrons, automated radiochemical synthesis equipment, and high-efficiency target systems have improved both production efficiency and supply reliability for short-lived radionuclides. Meanwhile, continuous improvements in radiochemical separation techniques, high-purity nuclide production methods, and quality control systems are enabling Scandium-43 to better meet the demands of scientific and clinical research. Looking ahead, the supply capacity for Scandium-43 is expected to gradually increase as regional nuclear medicine centers are established and accelerator networks are further developed.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Scandium-43 Industry Forecast” looks at past sales and reviews total world Scandium-43 sales in 2025, providing a comprehensive analysis by region and market sector of projected Scandium-43 sales for 2026 through 2032. With Scandium-43 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Scandium-43 industry.
This Insight Report provides a comprehensive analysis of the global Scandium-43 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Scandium-43 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Scandium-43 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Scandium-43 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Scandium-43.
This report presents a comprehensive overview, market shares, and growth opportunities of Scandium-43 market by product type, application, key manufacturers and key regions and countries.
In 2025, global Scandium-43 production was approximately 112 grams, with an average global market price of around $138,000 per gram. That year, total global production capacity for Scandium-43 reached approximately 350 grams. The industry's average gross profit margin stood at approximately 64%. Scandium-43 (?³Sc) is an artificial radioactive isotope of the transition metal scandium (Sc), with an atomic number of 21 and a mass number of 43. While scandium exists in nature primarily as the stable isotope scandium-45 (??Sc), ?³Sc does not occur naturally in significant quantities and must be produced via artificial nuclear reactions. With a half-life of approximately 3.89 hours, ?³Sc decays primarily via ?? emission into stable calcium-43 (?³Ca), releasing positrons in the process; this makes it a promising candidate for Positron Emission Tomography (PET) applications. Due to its short half-life, high positron emission fraction, and chemical properties suitable for ligand labeling, research on ?³Sc focuses on molecular imaging in nuclear medicine, radiopharmaceutical development, and the creation of novel PET imaging agents. Compared to established PET radionuclides like fluorine-18 (??F) and gallium-68 (??Ga), ?³Sc remains in the stages of research, development, and exploratory application; however, its excellent compatibility with scandium-based coordination chemistry positions it as a promising new radionuclide for the future of precision diagnostics in nuclear medicine.
The upstream segment of the ?³Sc industry chain encompasses the supply of stable scandium resources, the production of high-purity scandium target materials, isotope production facilities, and nuclear equipment such as cyclotrons. Since scandium exists in nature predominantly as the stable isotope ??Sc, ?³Sc must be generated through artificial nuclear reactions. Common production methods involve using enriched calcium, titanium, or scandium targets and subjecting them to nuclear reactions—such as proton bombardment—within a cyclotron. This upstream phase entails the preparation of high-purity target materials, the control of nuclear reaction parameters, and the construction of radionuclide production facilities, all of which demand advanced equipment and technical expertise. Given the inherent scarcity of scandium resources—which are primarily derived as by-products of rare earth and uranium mining or recovered during other mineral processing operations—the supply capacity for high-purity scandium materials is a critical factor influencing ?³Sc production. The global scale of scandium resource development and production remains limited, with supply concentrated among a few nations and institutions possessing capabilities in resource extraction and nuclear technology. The midstream of the Scandium-43 (?³Sc) value chain encompasses nuclear reactor-based production, radiochemical separation, purification, and the development of radiopharmaceutical labeling technologies. As accelerator-based production inevitably generates other scandium isotopes or impurity nuclides, radiochemical methods—such as ion exchange, solvent extraction, and chromatography—are required to obtain ?³Sc products with high radiochemical purity. Depending on application requirements, ?³Sc is typically supplied in chemical forms like scandium chloride solution and subsequently conjugated with targeting ligands, antibody fragments, or small-molecule drugs to develop radiotracers for PET imaging. The core technical challenges in the midstream sector involve maximizing nuclide yield, minimizing impurity levels, and achieving rapid labeling reactions to accommodate the constraints imposed by the relatively short half-life of ?³Sc. Current research on ?³Sc focuses primarily on developing novel PET imaging agents, evaluating radiopharmaceuticals, and establishing experimental platforms for nuclear medicine. Downstream applications of ?³Sc include nuclear medicine imaging, radiotracer research, and the development of precision diagnostic technologies. PET molecular imaging represents the most promising application area for ?³Sc; its positron-emitting properties enable the production of PET tracers for visualizing in vivo biodistribution, disease target expression, and drug metabolism. Additionally, ?³Sc is utilized in radiopharmaceutical R&D, tumor-targeted imaging, and research into novel theranostic (combined diagnostic and therapeutic) agents. Compared to traditional PET nuclides, ?³Sc offers advantages such as excellent compatibility with scandium coordination chemistry and nuclear properties well-suited for medical imaging; however, its adoption is currently constrained by factors including production costs, supply stability, and a lack of sufficient clinical validation. Looking ahead, advancements in compact cyclotron technology, rising demand for nuclear medicine diagnostics, and progress in novel radiopharmaceutical development position ?³Sc to become a significant complementary nuclide in the field of PET molecular imaging.
The primary driver for the development of Scandium-43 (?³Sc) is the advancement of precision medicine and nuclear medicine imaging technologies. As a positron-emitting radioisotope, ?³Sc undergoes ?? decay to produce positrons, enabling Positron Emission Tomography (PET) imaging that precisely visualizes human tissue metabolism, disease target expression, and drug distribution. With the continuous evolution of early tumor diagnosis, personalized therapy, and molecular imaging, market demand for novel PET radionuclides is steadily rising. Compared to traditional PET radionuclides, ?³Sc offers superior coordination chemistry compatibility, allowing it to bind with various targeting molecules to create new imaging agents—a feature that has attracted significant interest from nuclear medicine research institutions and radiopharmaceutical companies. Looking ahead, the adoption of precision diagnosis and treatment models, combined with the entry of more scandium-based PET tracers into the R&D pipeline, is expected to drive the expansion of ?³Sc applications.
In recent years, the radiopharmaceutical industry has been shifting from purely diagnostic applications toward an integrated "diagnosis and therapy" (theranostics) model, creating new opportunities for novel radionuclides like ?³Sc. Beyond its use in PET imaging research, ?³Sc complements scandium-based therapeutic radionuclide systems, facilitating drug screening, the evaluation of targeting molecules, and the design of treatment regimens. In the field of precision oncology, researchers are exploring the use of unified ligand systems to transition seamlessly between diagnostic imaging and radiotherapy; this trend is fueling demand for novel radionuclides that exhibit excellent chemical labeling properties. Furthermore, as radiopharmaceutical companies expand their pipelines for innovative drugs, the need for a reliable supply of high-purity radionuclides for research purposes is growing, further propelling the development of the ?³Sc industry.
A critical constraint on the development of the ?³Sc industry is the ability to ensure a stable supply. Due to its short half-life (approximately 3.89 hours), ?³Sc cannot be stored or transported over long distances for extended periods; consequently, production typically relies on cyclotron facilities located in close proximity to end-use sites. Recent advancements in compact medical cyclotrons, automated radiochemical synthesis equipment, and high-efficiency target systems have improved both production efficiency and supply reliability for short-lived radionuclides. Meanwhile, continuous improvements in radiochemical separation techniques, high-purity nuclide production methods, and quality control systems are enabling Scandium-43 to better meet the demands of scientific and clinical research. Looking ahead, the supply capacity for Scandium-43 is expected to gradually increase as regional nuclear medicine centers are established and accelerator networks are further developed.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Scandium-43 Industry Forecast” looks at past sales and reviews total world Scandium-43 sales in 2025, providing a comprehensive analysis by region and market sector of projected Scandium-43 sales for 2026 through 2032. With Scandium-43 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Scandium-43 industry.
This Insight Report provides a comprehensive analysis of the global Scandium-43 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Scandium-43 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Scandium-43 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Scandium-43 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Scandium-43.
This report presents a comprehensive overview, market shares, and growth opportunities of Scandium-43 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Radionuclidic Purity: 98%-99%
- Radionuclidic Purity: ?99%
Segmentation by Product Form:
- Scandium-43 Solution
- Scandium-43 Solid Compound
- Scandium-43 Standard Source
Segmentation by Chemical Purity:
- Research-grade Scandium-43
- High-radiochemical-purity Scandium-43
- Clinical-grade Scandium-43
Segmentation by Production Route:
- Cyclotron-produced Scandium-43
- Reactor-produced Scandium-43
- Generator-based Scandium-43
Segmentation by Application:
- Nuclear Medicine
- Scientific Research
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NIDC(DOE IP)
- Scandium Canada
- Rosatom
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Scandium-43 market?
- What factors are driving Scandium-43 market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Scandium-43 market opportunities vary by end market size?
- How does Scandium-43 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Scandium-43 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Scandium-43 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Scandium-43 by Country/Region, 2021, 2025 & 2032
2.2 Scandium-43 Segment by Type
2.2.1 Radionuclidic Purity: 98%-99%
2.2.2 Radionuclidic Purity: ?99%
2.2.3 Scandium-43 Sales by Type
2.2.3.1 Global Scandium-43 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Scandium-43 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Scandium-43 Sale Price by Type (2021-2026)
2.3 Scandium-43 Segment by Product Form
2.3.1 Scandium-43 Solution
2.3.2 Scandium-43 Solid Compound
2.3.3 Scandium-43 Standard Source
2.3.4 Scandium-43 Sales by Product Form
2.3.4.1 Global Scandium-43 Sales Market Share by Product Form (2021-2026)
2.3.4.2 Global Scandium-43 Revenue and Market Share by Product Form (2021-2026)
2.3.4.3 Global Scandium-43 Sale Price by Product Form (2021-2026)
2.4 Scandium-43 Segment by Chemical Purity
2.4.1 Research-grade Scandium-43
2.4.2 High-radiochemical-purity Scandium-43
2.4.3 Clinical-grade Scandium-43
2.4.4 Scandium-43 Sales by Chemical Purity
2.4.4.1 Global Scandium-43 Sales Market Share by Chemical Purity (2021-2026)
2.4.4.2 Global Scandium-43 Revenue and Market Share by Chemical Purity (2021-2026)
2.4.4.3 Global Scandium-43 Sale Price by Chemical Purity (2021-2026)
2.5 Scandium-43 Segment by Production Route
2.5.1 Cyclotron-produced Scandium-43
2.5.2 Reactor-produced Scandium-43
2.5.3 Generator-based Scandium-43
2.5.4 Scandium-43 Sales by Production Route
2.5.4.1 Global Scandium-43 Sales Market Share by Production Route (2021-2026)
2.5.4.2 Global Scandium-43 Revenue and Market Share by Production Route (2021-2026)
2.5.4.3 Global Scandium-43 Sale Price by Production Route (2021-2026)
2.6 Scandium-43 Segment by Application
2.6.1 Nuclear Medicine
2.6.2 Scientific Research
2.6.3 Scandium-43 Sales by Application
2.6.3.1 Global Scandium-43 Sale Market Share by Application (2021-2026)
2.6.3.2 Global Scandium-43 Revenue and Market Share by Application (2021-2026)
2.6.3.3 Global Scandium-43 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Scandium-43 Breakdown Data by Company
3.1.1 Global Scandium-43 Annual Sales by Company (2021-2026)
3.1.2 Global Scandium-43 Sales Market Share by Company (2021-2026)
3.2 Global Scandium-43 Annual Revenue by Company (2021-2026)
3.2.1 Global Scandium-43 Revenue by Company (2021-2026)
3.2.2 Global Scandium-43 Revenue Market Share by Company (2021-2026)
3.3 Global Scandium-43 Sale Price by Company
3.4 Key Manufacturers Scandium-43 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Scandium-43 Product Location Distribution
3.4.2 Players Scandium-43 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SCANDIUM-43 BY GEOGRAPHIC REGION
4.1 World Historic Scandium-43 Market Size by Geographic Region (2021-2026)
4.1.1 Global Scandium-43 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Scandium-43 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Scandium-43 Market Size by Country/Region (2021-2026)
4.2.1 Global Scandium-43 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Scandium-43 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Scandium-43 Sales Growth
4.4 APAC Scandium-43 Sales Growth
4.5 Europe Scandium-43 Sales Growth
4.6 Middle East & Africa Scandium-43 Sales Growth
5 AMERICAS
5.1 Americas Scandium-43 Sales by Country
5.1.1 Americas Scandium-43 Sales by Country (2021-2026)
5.1.2 Americas Scandium-43 Revenue by Country (2021-2026)
5.2 Americas Scandium-43 Sales by Type (2021-2026)
5.3 Americas Scandium-43 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Scandium-43 Sales by Region
6.1.1 APAC Scandium-43 Sales by Region (2021-2026)
6.1.2 APAC Scandium-43 Revenue by Region (2021-2026)
6.2 APAC Scandium-43 Sales by Type (2021-2026)
6.3 APAC Scandium-43 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Scandium-43 by Country
7.1.1 Europe Scandium-43 Sales by Country (2021-2026)
7.1.2 Europe Scandium-43 Revenue by Country (2021-2026)
7.2 Europe Scandium-43 Sales by Type (2021-2026)
7.3 Europe Scandium-43 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Scandium-43 by Country
8.1.1 Middle East & Africa Scandium-43 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Scandium-43 Revenue by Country (2021-2026)
8.2 Middle East & Africa Scandium-43 Sales by Type (2021-2026)
8.3 Middle East & Africa Scandium-43 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Scandium-43
10.3 Manufacturing Process Analysis of Scandium-43
10.4 Industry Chain Structure of Scandium-43
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Scandium-43 Distributors
11.3 Scandium-43 Customer
12 WORLD FORECAST REVIEW FOR SCANDIUM-43 BY GEOGRAPHIC REGION
12.1 Global Scandium-43 Market Size Forecast by Region
12.1.1 Global Scandium-43 Forecast by Region (2027-2032)
12.1.2 Global Scandium-43 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Scandium-43 Forecast by Type (2027-2032)
12.7 Global Scandium-43 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 NIDC(DOE IP)
13.1.1 NIDC(DOE IP) Company Information
13.1.2 NIDC(DOE IP) Scandium-43 Product Portfolios and Specifications
13.1.3 NIDC(DOE IP) Scandium-43 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 NIDC(DOE IP) Main Business Overview
13.1.5 NIDC(DOE IP) Latest Developments
13.2 Scandium Canada
13.2.1 Scandium Canada Company Information
13.2.2 Scandium Canada Scandium-43 Product Portfolios and Specifications
13.2.3 Scandium Canada Scandium-43 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Scandium Canada Main Business Overview
13.2.5 Scandium Canada Latest Developments
13.3 Rosatom
13.3.1 Rosatom Company Information
13.3.2 Rosatom Scandium-43 Product Portfolios and Specifications
13.3.3 Rosatom Scandium-43 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Rosatom Main Business Overview
13.3.5 Rosatom Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Scandium-43 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Scandium-43 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Scandium-43 by Country/Region, 2021, 2025 & 2032
2.2 Scandium-43 Segment by Type
2.2.1 Radionuclidic Purity: 98%-99%
2.2.2 Radionuclidic Purity: ?99%
2.2.3 Scandium-43 Sales by Type
2.2.3.1 Global Scandium-43 Sales Market Share by Type (2021-2026)
2.2.3.2 Global Scandium-43 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Scandium-43 Sale Price by Type (2021-2026)
2.3 Scandium-43 Segment by Product Form
2.3.1 Scandium-43 Solution
2.3.2 Scandium-43 Solid Compound
2.3.3 Scandium-43 Standard Source
2.3.4 Scandium-43 Sales by Product Form
2.3.4.1 Global Scandium-43 Sales Market Share by Product Form (2021-2026)
2.3.4.2 Global Scandium-43 Revenue and Market Share by Product Form (2021-2026)
2.3.4.3 Global Scandium-43 Sale Price by Product Form (2021-2026)
2.4 Scandium-43 Segment by Chemical Purity
2.4.1 Research-grade Scandium-43
2.4.2 High-radiochemical-purity Scandium-43
2.4.3 Clinical-grade Scandium-43
2.4.4 Scandium-43 Sales by Chemical Purity
2.4.4.1 Global Scandium-43 Sales Market Share by Chemical Purity (2021-2026)
2.4.4.2 Global Scandium-43 Revenue and Market Share by Chemical Purity (2021-2026)
2.4.4.3 Global Scandium-43 Sale Price by Chemical Purity (2021-2026)
2.5 Scandium-43 Segment by Production Route
2.5.1 Cyclotron-produced Scandium-43
2.5.2 Reactor-produced Scandium-43
2.5.3 Generator-based Scandium-43
2.5.4 Scandium-43 Sales by Production Route
2.5.4.1 Global Scandium-43 Sales Market Share by Production Route (2021-2026)
2.5.4.2 Global Scandium-43 Revenue and Market Share by Production Route (2021-2026)
2.5.4.3 Global Scandium-43 Sale Price by Production Route (2021-2026)
2.6 Scandium-43 Segment by Application
2.6.1 Nuclear Medicine
2.6.2 Scientific Research
2.6.3 Scandium-43 Sales by Application
2.6.3.1 Global Scandium-43 Sale Market Share by Application (2021-2026)
2.6.3.2 Global Scandium-43 Revenue and Market Share by Application (2021-2026)
2.6.3.3 Global Scandium-43 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Scandium-43 Breakdown Data by Company
3.1.1 Global Scandium-43 Annual Sales by Company (2021-2026)
3.1.2 Global Scandium-43 Sales Market Share by Company (2021-2026)
3.2 Global Scandium-43 Annual Revenue by Company (2021-2026)
3.2.1 Global Scandium-43 Revenue by Company (2021-2026)
3.2.2 Global Scandium-43 Revenue Market Share by Company (2021-2026)
3.3 Global Scandium-43 Sale Price by Company
3.4 Key Manufacturers Scandium-43 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Scandium-43 Product Location Distribution
3.4.2 Players Scandium-43 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SCANDIUM-43 BY GEOGRAPHIC REGION
4.1 World Historic Scandium-43 Market Size by Geographic Region (2021-2026)
4.1.1 Global Scandium-43 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Scandium-43 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Scandium-43 Market Size by Country/Region (2021-2026)
4.2.1 Global Scandium-43 Annual Sales by Country/Region (2021-2026)
4.2.2 Global Scandium-43 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Scandium-43 Sales Growth
4.4 APAC Scandium-43 Sales Growth
4.5 Europe Scandium-43 Sales Growth
4.6 Middle East & Africa Scandium-43 Sales Growth
5 AMERICAS
5.1 Americas Scandium-43 Sales by Country
5.1.1 Americas Scandium-43 Sales by Country (2021-2026)
5.1.2 Americas Scandium-43 Revenue by Country (2021-2026)
5.2 Americas Scandium-43 Sales by Type (2021-2026)
5.3 Americas Scandium-43 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Scandium-43 Sales by Region
6.1.1 APAC Scandium-43 Sales by Region (2021-2026)
6.1.2 APAC Scandium-43 Revenue by Region (2021-2026)
6.2 APAC Scandium-43 Sales by Type (2021-2026)
6.3 APAC Scandium-43 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Scandium-43 by Country
7.1.1 Europe Scandium-43 Sales by Country (2021-2026)
7.1.2 Europe Scandium-43 Revenue by Country (2021-2026)
7.2 Europe Scandium-43 Sales by Type (2021-2026)
7.3 Europe Scandium-43 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Scandium-43 by Country
8.1.1 Middle East & Africa Scandium-43 Sales by Country (2021-2026)
8.1.2 Middle East & Africa Scandium-43 Revenue by Country (2021-2026)
8.2 Middle East & Africa Scandium-43 Sales by Type (2021-2026)
8.3 Middle East & Africa Scandium-43 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Scandium-43
10.3 Manufacturing Process Analysis of Scandium-43
10.4 Industry Chain Structure of Scandium-43
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Scandium-43 Distributors
11.3 Scandium-43 Customer
12 WORLD FORECAST REVIEW FOR SCANDIUM-43 BY GEOGRAPHIC REGION
12.1 Global Scandium-43 Market Size Forecast by Region
12.1.1 Global Scandium-43 Forecast by Region (2027-2032)
12.1.2 Global Scandium-43 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Scandium-43 Forecast by Type (2027-2032)
12.7 Global Scandium-43 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 NIDC(DOE IP)
13.1.1 NIDC(DOE IP) Company Information
13.1.2 NIDC(DOE IP) Scandium-43 Product Portfolios and Specifications
13.1.3 NIDC(DOE IP) Scandium-43 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 NIDC(DOE IP) Main Business Overview
13.1.5 NIDC(DOE IP) Latest Developments
13.2 Scandium Canada
13.2.1 Scandium Canada Company Information
13.2.2 Scandium Canada Scandium-43 Product Portfolios and Specifications
13.2.3 Scandium Canada Scandium-43 Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Scandium Canada Main Business Overview
13.2.5 Scandium Canada Latest Developments
13.3 Rosatom
13.3.1 Rosatom Company Information
13.3.2 Rosatom Scandium-43 Product Portfolios and Specifications
13.3.3 Rosatom Scandium-43 Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Rosatom Main Business Overview
13.3.5 Rosatom Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Scandium-43 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Scandium-43 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Radionuclidic Purity: 98%-99%
Table 4. Major Players of Radionuclidic Purity: ?99%
Table 5. Global Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 6. Global Scandium-43 Sales Market Share by Type (2021-2026)
Table 7. Global Scandium-43 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Scandium-43 Revenue Market Share by Type (2021-2026)
Table 9. Global Scandium-43 Sale Price by Type (2021-2026) & (US$/g)
Table 10. Major Players of Scandium-43 Solution
Table 11. Major Players of Scandium-43 Solid Compound
Table 12. Major Players of Scandium-43 Standard Source
Table 13. Global Scandium-43 Sales by Product Form (2021-2026) & (Gram)
Table 14. Global Scandium-43 Sales Market Share by Product Form (2021-2026)
Table 15. Global Scandium-43 Revenue by Product Form (2021-2026) & ($ million)
Table 16. Global Scandium-43 Revenue Market Share by Product Form (2021-2026)
Table 17. Global Scandium-43 Sale Price by Product Form (2021-2026) & (US$/g)
Table 18. Major Players of Research-grade Scandium-43
Table 19. Major Players of High-radiochemical-purity Scandium-43
Table 20. Major Players of Clinical-grade Scandium-43
Table 21. Global Scandium-43 Sales by Chemical Purity (2021-2026) & (Gram)
Table 22. Global Scandium-43 Sales Market Share by Chemical Purity (2021-2026)
Table 23. Global Scandium-43 Revenue by Chemical Purity (2021-2026) & ($ million)
Table 24. Global Scandium-43 Revenue Market Share by Chemical Purity (2021-2026)
Table 25. Global Scandium-43 Sale Price by Chemical Purity (2021-2026) & (US$/g)
Table 26. Major Players of Cyclotron-produced Scandium-43
Table 27. Major Players of Reactor-produced Scandium-43
Table 28. Major Players of Generator-based Scandium-43
Table 29. Global Scandium-43 Sales by Production Route (2021-2026) & (Gram)
Table 30. Global Scandium-43 Sales Market Share by Production Route (2021-2026)
Table 31. Global Scandium-43 Revenue by Production Route (2021-2026) & ($ million)
Table 32. Global Scandium-43 Revenue Market Share by Production Route (2021-2026)
Table 33. Global Scandium-43 Sale Price by Production Route (2021-2026) & (US$/g)
Table 34. Global Scandium-43 Sale by Application (2021-2026) & (Gram)
Table 35. Global Scandium-43 Sale Market Share by Application (2021-2026)
Table 36. Global Scandium-43 Revenue by Application (2021-2026) & ($ million)
Table 37. Global Scandium-43 Revenue Market Share by Application (2021-2026)
Table 38. Global Scandium-43 Sale Price by Application (2021-2026) & (US$/g)
Table 39. Global Scandium-43 Sales by Company (2021-2026) & (Gram)
Table 40. Global Scandium-43 Sales Market Share by Company (2021-2026)
Table 41. Global Scandium-43 Revenue by Company (2021-2026) & ($ millions)
Table 42. Global Scandium-43 Revenue Market Share by Company (2021-2026)
Table 43. Global Scandium-43 Sale Price by Company (2021-2026) & (US$/g)
Table 44. Key Manufacturers Scandium-43 Producing Area Distribution and Sales Area
Table 45. Players Scandium-43 Products Offered
Table 46. Scandium-43 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 47. New Products and Potential Entrants
Table 48. Market M&A Activity & Strategy
Table 49. Global Scandium-43 Sales by Geographic Region (2021-2026) & (Gram)
Table 50. Global Scandium-43 Sales Market Share Geographic Region (2021-2026)
Table 51. Global Scandium-43 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 52. Global Scandium-43 Revenue Market Share by Geographic Region (2021-2026)
Table 53. Global Scandium-43 Sales by Country/Region (2021-2026) & (Gram)
Table 54. Global Scandium-43 Sales Market Share by Country/Region (2021-2026)
Table 55. Global Scandium-43 Revenue by Country/Region (2021-2026) & ($ millions)
Table 56. Global Scandium-43 Revenue Market Share by Country/Region (2021-2026)
Table 57. Americas Scandium-43 Sales by Country (2021-2026) & (Gram)
Table 58. Americas Scandium-43 Sales Market Share by Country (2021-2026)
Table 59. Americas Scandium-43 Revenue by Country (2021-2026) & ($ millions)
Table 60. Americas Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 61. Americas Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 62. APAC Scandium-43 Sales by Region (2021-2026) & (Gram)
Table 63. APAC Scandium-43 Sales Market Share by Region (2021-2026)
Table 64. APAC Scandium-43 Revenue by Region (2021-2026) & ($ millions)
Table 65. APAC Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 66. APAC Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 67. Europe Scandium-43 Sales by Country (2021-2026) & (Gram)
Table 68. Europe Scandium-43 Revenue by Country (2021-2026) & ($ millions)
Table 69. Europe Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 70. Europe Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 71. Middle East & Africa Scandium-43 Sales by Country (2021-2026) & (Gram)
Table 72. Middle East & Africa Scandium-43 Revenue Market Share by Country (2021-2026)
Table 73. Middle East & Africa Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 74. Middle East & Africa Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 75. Key Market Drivers & Growth Opportunities of Scandium-43
Table 76. Key Market Challenges & Risks of Scandium-43
Table 77. Key Industry Trends of Scandium-43
Table 78. Scandium-43 Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Scandium-43 Distributors List
Table 81. Scandium-43 Customer List
Table 82. Global Scandium-43 Sales Forecast by Region (2027-2032) & (Gram)
Table 83. Global Scandium-43 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Americas Scandium-43 Sales Forecast by Country (2027-2032) & (Gram)
Table 85. Americas Scandium-43 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. APAC Scandium-43 Sales Forecast by Region (2027-2032) & (Gram)
Table 87. APAC Scandium-43 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 88. Europe Scandium-43 Sales Forecast by Country (2027-2032) & (Gram)
Table 89. Europe Scandium-43 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Middle East & Africa Scandium-43 Sales Forecast by Country (2027-2032) & (Gram)
Table 91. Middle East & Africa Scandium-43 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Global Scandium-43 Sales Forecast by Type (2027-2032) & (Gram)
Table 93. Global Scandium-43 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 94. Global Scandium-43 Sales Forecast by Application (2027-2032) & (Gram)
Table 95. Global Scandium-43 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 96. NIDC(DOE IP) Basic Information, Scandium-43 Manufacturing Base, Sales Area and Its Competitors
Table 97. NIDC(DOE IP) Scandium-43 Product Portfolios and Specifications
Table 98. NIDC(DOE IP) Scandium-43 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 99. NIDC(DOE IP) Main Business
Table 100. NIDC(DOE IP) Latest Developments
Table 101. Scandium Canada Basic Information, Scandium-43 Manufacturing Base, Sales Area and Its Competitors
Table 102. Scandium Canada Scandium-43 Product Portfolios and Specifications
Table 103. Scandium Canada Scandium-43 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 104. Scandium Canada Main Business
Table 105. Scandium Canada Latest Developments
Table 106. Rosatom Basic Information, Scandium-43 Manufacturing Base, Sales Area and Its Competitors
Table 107. Rosatom Scandium-43 Product Portfolios and Specifications
Table 108. Rosatom Scandium-43 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 109. Rosatom Main Business
Table 110. Rosatom Latest Developments
Table 1. Scandium-43 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Scandium-43 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Radionuclidic Purity: 98%-99%
Table 4. Major Players of Radionuclidic Purity: ?99%
Table 5. Global Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 6. Global Scandium-43 Sales Market Share by Type (2021-2026)
Table 7. Global Scandium-43 Revenue by Type (2021-2026) & ($ million)
Table 8. Global Scandium-43 Revenue Market Share by Type (2021-2026)
Table 9. Global Scandium-43 Sale Price by Type (2021-2026) & (US$/g)
Table 10. Major Players of Scandium-43 Solution
Table 11. Major Players of Scandium-43 Solid Compound
Table 12. Major Players of Scandium-43 Standard Source
Table 13. Global Scandium-43 Sales by Product Form (2021-2026) & (Gram)
Table 14. Global Scandium-43 Sales Market Share by Product Form (2021-2026)
Table 15. Global Scandium-43 Revenue by Product Form (2021-2026) & ($ million)
Table 16. Global Scandium-43 Revenue Market Share by Product Form (2021-2026)
Table 17. Global Scandium-43 Sale Price by Product Form (2021-2026) & (US$/g)
Table 18. Major Players of Research-grade Scandium-43
Table 19. Major Players of High-radiochemical-purity Scandium-43
Table 20. Major Players of Clinical-grade Scandium-43
Table 21. Global Scandium-43 Sales by Chemical Purity (2021-2026) & (Gram)
Table 22. Global Scandium-43 Sales Market Share by Chemical Purity (2021-2026)
Table 23. Global Scandium-43 Revenue by Chemical Purity (2021-2026) & ($ million)
Table 24. Global Scandium-43 Revenue Market Share by Chemical Purity (2021-2026)
Table 25. Global Scandium-43 Sale Price by Chemical Purity (2021-2026) & (US$/g)
Table 26. Major Players of Cyclotron-produced Scandium-43
Table 27. Major Players of Reactor-produced Scandium-43
Table 28. Major Players of Generator-based Scandium-43
Table 29. Global Scandium-43 Sales by Production Route (2021-2026) & (Gram)
Table 30. Global Scandium-43 Sales Market Share by Production Route (2021-2026)
Table 31. Global Scandium-43 Revenue by Production Route (2021-2026) & ($ million)
Table 32. Global Scandium-43 Revenue Market Share by Production Route (2021-2026)
Table 33. Global Scandium-43 Sale Price by Production Route (2021-2026) & (US$/g)
Table 34. Global Scandium-43 Sale by Application (2021-2026) & (Gram)
Table 35. Global Scandium-43 Sale Market Share by Application (2021-2026)
Table 36. Global Scandium-43 Revenue by Application (2021-2026) & ($ million)
Table 37. Global Scandium-43 Revenue Market Share by Application (2021-2026)
Table 38. Global Scandium-43 Sale Price by Application (2021-2026) & (US$/g)
Table 39. Global Scandium-43 Sales by Company (2021-2026) & (Gram)
Table 40. Global Scandium-43 Sales Market Share by Company (2021-2026)
Table 41. Global Scandium-43 Revenue by Company (2021-2026) & ($ millions)
Table 42. Global Scandium-43 Revenue Market Share by Company (2021-2026)
Table 43. Global Scandium-43 Sale Price by Company (2021-2026) & (US$/g)
Table 44. Key Manufacturers Scandium-43 Producing Area Distribution and Sales Area
Table 45. Players Scandium-43 Products Offered
Table 46. Scandium-43 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 47. New Products and Potential Entrants
Table 48. Market M&A Activity & Strategy
Table 49. Global Scandium-43 Sales by Geographic Region (2021-2026) & (Gram)
Table 50. Global Scandium-43 Sales Market Share Geographic Region (2021-2026)
Table 51. Global Scandium-43 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 52. Global Scandium-43 Revenue Market Share by Geographic Region (2021-2026)
Table 53. Global Scandium-43 Sales by Country/Region (2021-2026) & (Gram)
Table 54. Global Scandium-43 Sales Market Share by Country/Region (2021-2026)
Table 55. Global Scandium-43 Revenue by Country/Region (2021-2026) & ($ millions)
Table 56. Global Scandium-43 Revenue Market Share by Country/Region (2021-2026)
Table 57. Americas Scandium-43 Sales by Country (2021-2026) & (Gram)
Table 58. Americas Scandium-43 Sales Market Share by Country (2021-2026)
Table 59. Americas Scandium-43 Revenue by Country (2021-2026) & ($ millions)
Table 60. Americas Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 61. Americas Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 62. APAC Scandium-43 Sales by Region (2021-2026) & (Gram)
Table 63. APAC Scandium-43 Sales Market Share by Region (2021-2026)
Table 64. APAC Scandium-43 Revenue by Region (2021-2026) & ($ millions)
Table 65. APAC Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 66. APAC Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 67. Europe Scandium-43 Sales by Country (2021-2026) & (Gram)
Table 68. Europe Scandium-43 Revenue by Country (2021-2026) & ($ millions)
Table 69. Europe Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 70. Europe Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 71. Middle East & Africa Scandium-43 Sales by Country (2021-2026) & (Gram)
Table 72. Middle East & Africa Scandium-43 Revenue Market Share by Country (2021-2026)
Table 73. Middle East & Africa Scandium-43 Sales by Type (2021-2026) & (Gram)
Table 74. Middle East & Africa Scandium-43 Sales by Application (2021-2026) & (Gram)
Table 75. Key Market Drivers & Growth Opportunities of Scandium-43
Table 76. Key Market Challenges & Risks of Scandium-43
Table 77. Key Industry Trends of Scandium-43
Table 78. Scandium-43 Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Scandium-43 Distributors List
Table 81. Scandium-43 Customer List
Table 82. Global Scandium-43 Sales Forecast by Region (2027-2032) & (Gram)
Table 83. Global Scandium-43 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Americas Scandium-43 Sales Forecast by Country (2027-2032) & (Gram)
Table 85. Americas Scandium-43 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. APAC Scandium-43 Sales Forecast by Region (2027-2032) & (Gram)
Table 87. APAC Scandium-43 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 88. Europe Scandium-43 Sales Forecast by Country (2027-2032) & (Gram)
Table 89. Europe Scandium-43 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Middle East & Africa Scandium-43 Sales Forecast by Country (2027-2032) & (Gram)
Table 91. Middle East & Africa Scandium-43 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Global Scandium-43 Sales Forecast by Type (2027-2032) & (Gram)
Table 93. Global Scandium-43 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 94. Global Scandium-43 Sales Forecast by Application (2027-2032) & (Gram)
Table 95. Global Scandium-43 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 96. NIDC(DOE IP) Basic Information, Scandium-43 Manufacturing Base, Sales Area and Its Competitors
Table 97. NIDC(DOE IP) Scandium-43 Product Portfolios and Specifications
Table 98. NIDC(DOE IP) Scandium-43 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 99. NIDC(DOE IP) Main Business
Table 100. NIDC(DOE IP) Latest Developments
Table 101. Scandium Canada Basic Information, Scandium-43 Manufacturing Base, Sales Area and Its Competitors
Table 102. Scandium Canada Scandium-43 Product Portfolios and Specifications
Table 103. Scandium Canada Scandium-43 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 104. Scandium Canada Main Business
Table 105. Scandium Canada Latest Developments
Table 106. Rosatom Basic Information, Scandium-43 Manufacturing Base, Sales Area and Its Competitors
Table 107. Rosatom Scandium-43 Product Portfolios and Specifications
Table 108. Rosatom Scandium-43 Sales (Gram), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 109. Rosatom Main Business
Table 110. Rosatom Latest Developments
LIST OF FIGURES
Figure 1. Picture of Scandium-43
Figure 2. Scandium-43 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Scandium-43 Sales Growth Rate 2021-2032 (Gram)
Figure 7. Global Scandium-43 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Scandium-43 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Scandium-43 Sales Market Share by Country/Region (2025)
Figure 10. Scandium-43 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Radionuclidic Purity: 98%-99%
Figure 12. Product Picture of Radionuclidic Purity: ?99%
Figure 13. Global Scandium-43 Sales Market Share by Type in 2026
Figure 14. Global Scandium-43 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Scandium-43 Solution
Figure 16. Product Picture of Scandium-43 Solid Compound
Figure 17. Product Picture of Scandium-43 Standard Source
Figure 18. Global Scandium-43 Sales Market Share by Product Form in 2026
Figure 19. Global Scandium-43 Revenue Market Share by Product Form (2021-2026)
Figure 20. Product Picture of Research-grade Scandium-43
Figure 21. Product Picture of High-radiochemical-purity Scandium-43
Figure 22. Product Picture of Clinical-grade Scandium-43
Figure 23. Global Scandium-43 Sales Market Share by Chemical Purity in 2026
Figure 24. Global Scandium-43 Revenue Market Share by Chemical Purity (2021-2026)
Figure 25. Product Picture of Cyclotron-produced Scandium-43
Figure 26. Product Picture of Reactor-produced Scandium-43
Figure 27. Product Picture of Generator-based Scandium-43
Figure 28. Global Scandium-43 Sales Market Share by Production Route in 2026
Figure 29. Global Scandium-43 Revenue Market Share by Production Route (2021-2026)
Figure 30. Scandium-43 Consumed in Nuclear Medicine
Figure 31. Global Scandium-43 Market: Nuclear Medicine (2021-2026) & (Gram)
Figure 32. Scandium-43 Consumed in Scientific Research
Figure 33. Global Scandium-43 Market: Scientific Research (2021-2026) & (Gram)
Figure 34. Global Scandium-43 Sale Market Share by Application (2025)
Figure 35. Global Scandium-43 Revenue Market Share by Application in 2025
Figure 36. Scandium-43 Sales by Company in 2025 (Gram)
Figure 37. Global Scandium-43 Sales Market Share by Company in 2025
Figure 38. Scandium-43 Revenue by Company in 2025 ($ millions)
Figure 39. Global Scandium-43 Revenue Market Share by Company in 2025
Figure 40. Global Scandium-43 Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Scandium-43 Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Scandium-43 Sales 2021-2026 (Gram)
Figure 43. Americas Scandium-43 Revenue 2021-2026 ($ millions)
Figure 44. APAC Scandium-43 Sales 2021-2026 (Gram)
Figure 45. APAC Scandium-43 Revenue 2021-2026 ($ millions)
Figure 46. Europe Scandium-43 Sales 2021-2026 (Gram)
Figure 47. Europe Scandium-43 Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Scandium-43 Sales 2021-2026 (Gram)
Figure 49. Middle East & Africa Scandium-43 Revenue 2021-2026 ($ millions)
Figure 50. Americas Scandium-43 Sales Market Share by Country in 2025
Figure 51. Americas Scandium-43 Revenue Market Share by Country (2021-2026)
Figure 52. Americas Scandium-43 Sales Market Share by Type (2021-2026)
Figure 53. Americas Scandium-43 Sales Market Share by Application (2021-2026)
Figure 54. United States Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Scandium-43 Sales Market Share by Region in 2025
Figure 59. APAC Scandium-43 Revenue Market Share by Region (2021-2026)
Figure 60. APAC Scandium-43 Sales Market Share by Type (2021-2026)
Figure 61. APAC Scandium-43 Sales Market Share by Application (2021-2026)
Figure 62. China Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 66. India Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Scandium-43 Sales Market Share by Country in 2025
Figure 70. Europe Scandium-43 Revenue Market Share by Country (2021-2026)
Figure 71. Europe Scandium-43 Sales Market Share by Type (2021-2026)
Figure 72. Europe Scandium-43 Sales Market Share by Application (2021-2026)
Figure 73. Germany Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 74. France Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Scandium-43 Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Scandium-43 Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Scandium-43 Sales Market Share by Application (2021-2026)
Figure 81. Egypt Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Scandium-43 in 2026
Figure 87. Manufacturing Process Analysis of Scandium-43
Figure 88. Industry Chain Structure of Scandium-43
Figure 89. Channels of Distribution
Figure 90. Global Scandium-43 Sales Market Forecast by Region (2027-2032)
Figure 91. Global Scandium-43 Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Scandium-43 Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Scandium-43 Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Scandium-43 Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Scandium-43 Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Scandium-43
Figure 2. Scandium-43 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Scandium-43 Sales Growth Rate 2021-2032 (Gram)
Figure 7. Global Scandium-43 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Scandium-43 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Scandium-43 Sales Market Share by Country/Region (2025)
Figure 10. Scandium-43 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Radionuclidic Purity: 98%-99%
Figure 12. Product Picture of Radionuclidic Purity: ?99%
Figure 13. Global Scandium-43 Sales Market Share by Type in 2026
Figure 14. Global Scandium-43 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Scandium-43 Solution
Figure 16. Product Picture of Scandium-43 Solid Compound
Figure 17. Product Picture of Scandium-43 Standard Source
Figure 18. Global Scandium-43 Sales Market Share by Product Form in 2026
Figure 19. Global Scandium-43 Revenue Market Share by Product Form (2021-2026)
Figure 20. Product Picture of Research-grade Scandium-43
Figure 21. Product Picture of High-radiochemical-purity Scandium-43
Figure 22. Product Picture of Clinical-grade Scandium-43
Figure 23. Global Scandium-43 Sales Market Share by Chemical Purity in 2026
Figure 24. Global Scandium-43 Revenue Market Share by Chemical Purity (2021-2026)
Figure 25. Product Picture of Cyclotron-produced Scandium-43
Figure 26. Product Picture of Reactor-produced Scandium-43
Figure 27. Product Picture of Generator-based Scandium-43
Figure 28. Global Scandium-43 Sales Market Share by Production Route in 2026
Figure 29. Global Scandium-43 Revenue Market Share by Production Route (2021-2026)
Figure 30. Scandium-43 Consumed in Nuclear Medicine
Figure 31. Global Scandium-43 Market: Nuclear Medicine (2021-2026) & (Gram)
Figure 32. Scandium-43 Consumed in Scientific Research
Figure 33. Global Scandium-43 Market: Scientific Research (2021-2026) & (Gram)
Figure 34. Global Scandium-43 Sale Market Share by Application (2025)
Figure 35. Global Scandium-43 Revenue Market Share by Application in 2025
Figure 36. Scandium-43 Sales by Company in 2025 (Gram)
Figure 37. Global Scandium-43 Sales Market Share by Company in 2025
Figure 38. Scandium-43 Revenue by Company in 2025 ($ millions)
Figure 39. Global Scandium-43 Revenue Market Share by Company in 2025
Figure 40. Global Scandium-43 Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Scandium-43 Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Scandium-43 Sales 2021-2026 (Gram)
Figure 43. Americas Scandium-43 Revenue 2021-2026 ($ millions)
Figure 44. APAC Scandium-43 Sales 2021-2026 (Gram)
Figure 45. APAC Scandium-43 Revenue 2021-2026 ($ millions)
Figure 46. Europe Scandium-43 Sales 2021-2026 (Gram)
Figure 47. Europe Scandium-43 Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Scandium-43 Sales 2021-2026 (Gram)
Figure 49. Middle East & Africa Scandium-43 Revenue 2021-2026 ($ millions)
Figure 50. Americas Scandium-43 Sales Market Share by Country in 2025
Figure 51. Americas Scandium-43 Revenue Market Share by Country (2021-2026)
Figure 52. Americas Scandium-43 Sales Market Share by Type (2021-2026)
Figure 53. Americas Scandium-43 Sales Market Share by Application (2021-2026)
Figure 54. United States Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Scandium-43 Sales Market Share by Region in 2025
Figure 59. APAC Scandium-43 Revenue Market Share by Region (2021-2026)
Figure 60. APAC Scandium-43 Sales Market Share by Type (2021-2026)
Figure 61. APAC Scandium-43 Sales Market Share by Application (2021-2026)
Figure 62. China Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 66. India Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Scandium-43 Sales Market Share by Country in 2025
Figure 70. Europe Scandium-43 Revenue Market Share by Country (2021-2026)
Figure 71. Europe Scandium-43 Sales Market Share by Type (2021-2026)
Figure 72. Europe Scandium-43 Sales Market Share by Application (2021-2026)
Figure 73. Germany Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 74. France Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Scandium-43 Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Scandium-43 Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Scandium-43 Sales Market Share by Application (2021-2026)
Figure 81. Egypt Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Scandium-43 Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Scandium-43 in 2026
Figure 87. Manufacturing Process Analysis of Scandium-43
Figure 88. Industry Chain Structure of Scandium-43
Figure 89. Channels of Distribution
Figure 90. Global Scandium-43 Sales Market Forecast by Region (2027-2032)
Figure 91. Global Scandium-43 Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Scandium-43 Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Scandium-43 Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Scandium-43 Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Scandium-43 Revenue Market Share Forecast by Application (2027-2032)
